Life ScienceCompany
Repligen M&A Summary
Repligen has acquired 11 companies, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Repligen’s largest acquisition to date was in 2017, when it acquired Spectrum Laboratories for $359M. Repligen has acquired in 4 different US states, and 6 countries. The Company’s most targeted sectors include medical products (37%) and life science (28%).
Repligen Business Overview
Where is Repligen headquartered?
Repligen is headquartered in Waltham, Massachusetts.
What is Repligen’s revenue?
Repligen disclosed revenue of 639M USD for 2023 and 802M USD for 2022.
How many employees does Repligen have?
Repligen has 1,123 employees.
What sector is Repligen in?
Repligen is a life science company.
When was Repligen founded?
Repligen was founded in 1981.
M&A Summary
-
M&A Total Activity12
- M&A Buy Activity11
- M&A Sell Activity1
- Total Sectors Invested 4
- Total Countries Invested 6
- M&A Buy/Sell Connections 3
- M&A Advisors 6